|
A
randomized controlled study of Velcade (Bortezomib) plus Thalidomide
plus Dexamethasone compared to Thalidomide plus Dexamethasone for
the treatment of myeloma patients progressing or relapsing after
autologous transplantation.
Trial
management center:
Trial
Co-ordination:
EBMT
Clinical Trials Office London
Trial
Co-ordinator:
Georgia Bullock
(Tel:
+44-207-188-8404)
Data
Management:
Menno van den Bosch
(Tel: +31-71-526-9727)
Coordinating
investigator:
Laurent
Garderet
(Paris)
Statistician:
Simona Iacobelli (Rome)
|